GlaxoSmithKline Buys Novartis Share Of Health Unit For $13 Billion
GlaxoSmithKline will spend $13 billion to buy out Novartis' 36.5% stake in its consumer health unit in a transaction expected to close in the second quarter.
GlaxoSmithKline will spend $13 billion to buy out Novartis' 36.5% stake in its consumer health unit in a transaction expected to close in the second quarter.